AC-11 Extract Enhances Cognition in Healthy Individuals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cognitive enhancement primarily focus on reversing mental decline in individuals with cognitive impairments, such as those with Alzheimer's disease, and lack effective methods for enhancing cognition in individuals with normal cognitive function.
Innovation Solution
The use of carboxy alkyl esters (CAEs) derived from Uncaria tomentosa, specifically extracted and purified through a process involving heating the vine's bark in water and ultra-filtration, is administered orally to enhance attention, memory, executive function, and social cognition in individuals with normal cognition, as demonstrated in a randomized double-blind cross-over placebo controlled pilot experiment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If treatments focus on reversing mental decline in individuals with cognitive impairments, then cognitive function in impaired individuals may improve, but no effective method exists for enhancing cognition in individuals with normal cognitive function
Solution Approach 1:
The patent changes the target parameter from treating cognitive impairment to enhancing normal cognitive function. By identifying that healthy individuals have lower baseline levels of neurotrophic factors compared to what is optimal for peak performance, the invention applies parameter changes to shift from a therapeutic context to an enhancement context, thereby resolving the contradiction between effectiveness for impaired individuals and applicability to normal individuals.
2Reliability
If substances are administered to treat Alzheimer's disease and cognitive decline, then symptoms may be reversed, but cognition in already healthy individuals remains unchanged or unenhanced
Solution Approach 1:
The patent inverts the traditional approach by not starting with cognitive decline as the baseline, but rather with normal cognition as the starting point for enhancement. Instead of asking how to reverse decline, the invention asks how to push normal cognition beyond its baseline, thereby inverting the problem statement and achieving both treatment efficacy and performance enhancement.
Solution Approach 2:
The invention changes the target parameter from maintaining or restoring minimum cognitive function to maximizing cognitive performance. By identifying that healthy brains operate below their potential due to insufficient neurotrophic support, the patent applies parameter changes to elevate cognitive function from normal to enhanced levels, thereby resolving the contradiction between treatment efficacy and productivity enhancement.
3Reliability
If conventional treatments are designed for pathological conditions, then they address disease states, but they fail to provide benefits for healthy individuals seeking cognitive improvement
Solution Approach 1:
The patent applies universality by creating a treatment that serves multiple functions: it effectively treats cognitive decline in impaired individuals while simultaneously enhancing cognition in healthy individuals. The composition of neurotrophic factors and their agonists provides universal benefit across the spectrum of cognitive health, thereby resolving the contradiction between effectiveness for the intended target group and adaptability across different health statuses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Daily oral intake of Uncaria tomentosa in the form of AC-11® pills results in statistically significant improvements in attention, memory, and executive function, with persistent improvements in attention and potential benefits to social cognition, showcasing a safe and effective method for cognitive enhancement in healthy individuals with normal cognition.
Implementation Method 1
heating the vine's bark in water
Implementation Method 2
ultra-filtration
Data Source
AI summary
AC-11® is a federally registered trademark covering a product consisting of an aqueous extract of the botanical Uncaria tomentosa. Applicants have found that administration of AC-11® product in a pharmaceutically effective amount and for a sufficient time period results in enhancement of cognition in people with normal cognition prior to commencing administration. The method of administering the AC-11® product is disclosed and claimed.